Brokerages Anticipate Sabra Health Care REIT, Inc. (NASDAQ:SBRA) to Post $0.36 EPS

Equities research analysts expect Sabra Health Care REIT, Inc. (NASDAQ:SBRA) to announce earnings per share of $0.36 for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Sabra Health Care REIT’s earnings, with the lowest EPS estimate coming in at $0.30 and the highest estimate coming in at $0.38. Sabra Health Care REIT posted earnings of $0.42 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 14.3%. The business is scheduled to report its next quarterly earnings results on Monday, February 28th.

On average, analysts expect that Sabra Health Care REIT will report full-year earnings of $1.53 per share for the current financial year, with EPS estimates ranging from $1.45 to $1.57. For the next year, analysts anticipate that the company will report earnings of $1.58 per share, with EPS estimates ranging from $1.49 to $1.64. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, November 3rd. The real estate investment trust reported $0.05 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.32). Sabra Health Care REIT had a negative net margin of 8.84% and a negative return on equity of 1.52%. During the same period last year, the business posted $0.46 earnings per share.

Several research firms recently issued reports on SBRA. Zacks Investment Research downgraded Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Thursday, January 6th. Truist Securities upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a report on Thursday, September 30th. Truist Financial upgraded Sabra Health Care REIT to a “buy” rating and set a $18.00 price objective on the stock in a report on Thursday, September 30th. Truist upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a report on Thursday, September 30th. Finally, Robert W. Baird began coverage on Sabra Health Care REIT in a report on Thursday, October 7th. They issued an “outperform” rating and a $18.00 price objective on the stock. One analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $18.63.

In other news, CFO Harold W. Jr. Andrews sold 110,000 shares of the stock in a transaction dated Wednesday, December 29th. The stock was sold at an average price of $13.55, for a total value of $1,490,500.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.10% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Total Clarity Wealth Management Inc. acquired a new stake in shares of Sabra Health Care REIT in the 3rd quarter valued at about $26,000. Future Financial Wealth Managment LLC acquired a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at about $41,000. Advisory Services Network LLC acquired a new stake in shares of Sabra Health Care REIT in the 2nd quarter valued at about $46,000. PSI Advisors LLC acquired a new stake in Sabra Health Care REIT during the 3rd quarter worth approximately $63,000. Finally, Lazard Asset Management LLC lifted its position in Sabra Health Care REIT by 114.5% during the 2nd quarter. Lazard Asset Management LLC now owns 4,007 shares of the real estate investment trust’s stock worth $72,000 after acquiring an additional 2,139 shares during the period. 84.59% of the stock is owned by hedge funds and other institutional investors.

Shares of Sabra Health Care REIT stock opened at $14.31 on Wednesday. Sabra Health Care REIT has a 52 week low of $12.31 and a 52 week high of $19.01. The business’s fifty day simple moving average is $13.75 and its 200-day simple moving average is $15.60. The firm has a market cap of $3.27 billion, a PE ratio of -65.05 and a beta of 1.44. The company has a quick ratio of 5.18, a current ratio of 5.18 and a debt-to-equity ratio of 0.81.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 30th. Stockholders of record on Tuesday, November 16th were issued a $0.30 dividend. The ex-dividend date was Monday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.39%. Sabra Health Care REIT’s payout ratio is currently -545.45%.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Recommended Story: Diversification in Investing

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.